Effects of remoxipride and some related new substituted salicylamides on rat brain receptors.
暂无分享,去创建一个
[1] H. Hall,et al. Effect of lipophilicity of substituted benzamides on the dopaminergic effects in vivo and in vitro. , 2009, Acta pharmacologica et toxicologica.
[2] C. Köhler,et al. Dopamine D2 receptors and dopamine metabolism Relationship between biochemical and behavioural effects of substituted benzamide drugs , 1986, Neuropharmacology.
[3] H. Hall,et al. Regional in vivo binding of the substituted benzamide [3H]eticlopride in the rat brain: evidence for selective labelling of dopamine receptors. , 1986, European journal of pharmacology.
[4] Y. Kumar,et al. POTENTIAL NEUROLEPTIC AGENTS. 3. CHEMISTRY AND ANTIDOPAMINERGIC PROPERTIES OF F SUBSTITUTED 6-METHOXYSALICYLAMIDES , 1985 .
[5] S. Ögren,et al. SYNTHESIS, CRYSTAL STRUCTURE AND ANTIDOPAMINERGIC PROPERTIES OF ETICLOPRIDE (FLB 131) , 1985 .
[6] Y. Kumar,et al. Potential neuroleptic agents. 3. Chemistry and antidopaminergic properties of substituted 6-methoxysalicylamides. , 1985, Journal of medicinal chemistry.
[7] S O Ogren,et al. Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain. , 1985, Biochemical pharmacology.
[8] H. Hall,et al. Some in vitro receptor binding properties of [3H]eticlopride, a novel substituted benzamide, selective for dopamine-D2 receptors in the rat brain. , 1985, European journal of pharmacology.
[9] E. Richelson,et al. Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro. , 1984, European journal of pharmacology.
[10] H. Hall,et al. Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain. , 1984, European journal of pharmacology.
[11] J. Gerlach,et al. NEW DRUGS AND PERSPECTIVES IN ANTIPSYCHOTIC TREATMENT , 1984 .
[12] K. Fuxe,et al. Studies on the Mechanism of Action of Substituted Benzamide Drugs , 1984, Acta psychiatrica Scandinavica. Supplementum.
[13] P. Jenner,et al. Multiple Dopamine Receptors in Brain and the Pharmacological Action of Substituted Benzamide Drugs , 1984, Acta psychiatrica Scandinavica. Supplementum.
[14] S. Ogren,et al. Potential neuroleptic agents. 2,6-Dialkoxybenzamide derivatives with potent dopamine receptor blocking activities. , 1982, Journal of medicinal chemistry.
[15] C. Marsden,et al. Substituted benzamide drugs as selective neuroleptic agents. , 1981, Neuropharmacology.
[16] S. Snyder,et al. Two distinct central serotonin receptors with different physiological functions. , 1981, Science.
[17] H. Hall,et al. Effects of antidepressant drugs on different receptors in the brain. , 1981, European journal of pharmacology.
[18] P. Seeman. Brain dopamine receptors. , 1980, Pharmacological reviews.
[19] C. Marsden,et al. The substituted benzamides--a novel class of dopamine antagonists. , 1979, Life sciences.
[20] H. Hall,et al. Evaluation of a semiautomatic filtration technique for receptor binding studies. , 1979, Life sciences.
[21] P. Seeman,et al. Anti-schizophrenic drugs--membrane receptor sites of action. , 1977, Biochemical pharmacology.
[22] D. Roberts,et al. Synthesis and pharmacological properties of a series of antidopaminergic piperidyl benzamides * , 1977, The Journal of pharmacy and pharmacology.
[23] S. Snyder,et al. Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes. , 1976, Molecular pharmacology.
[24] P. Greengard,et al. Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor". , 1972, Proceedings of the National Academy of Sciences of the United States of America.
[25] P. Seeman,et al. Conversion of dopamine D1 receptors from high to low affinity for dopamine. , 1985, Biochemical pharmacology.
[26] D. Sibley,et al. The classification of dopamine receptors: relationship to radioligand binding. , 1983, Annual review of neuroscience.